Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation

Metabolism: Clinical and Experimental

Volumn 56, Issue 12, 2007, Pages 1652-1655

  Wang, Zhong Q ^a   Qin, Jianhua ^a   Martin, Julie ^b   Zhang, Xian H ^a   Sereda, Olga ^a   Anderson, Richard A ^c   Pinsonat, Patricia ^a   Cefalu, William T ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM PICOLINATE; FAT; INSULIN; PLACEBO;

ADULT; ARTICLE; BODY FAT; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLYCEMIC CONTROL; HUMAN; IN VIVO STUDY; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; CHROMIUM; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED;

EID: 35848933686     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.07.007     Document Type: Article

References (11)

1. Cefalu W.T., and Hu F.B. Role of chromium in human health and in diabetes. Diabetes Care 27 (2004) 2742-2751
2. Martin J., Wang Z.Q., Zhang X.H., Wachtel D., Volaufova J., Matthews D.E., et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 29 (2006) 1826-1832
3. Anderson R.A., Cheng N., Bryden N.A., Polansky M.M., Cheng N., Chi J., et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46 (1997) 1786-1791
4. Kleefstra N., Houweling S.T., Jansman F.G.A., Groenier K.H., Gans R.O.B., Meyboom-de Jong B., et al. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 29 (2006) 521-525
5. Wang Z.Q., Zhang X.H., Russell J.C., Hulver M., and Cefalu W.T. Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. J Nutr 136 (2006) 415-420
6. Cefalu W.T., Wang Z.Q., Zhang X.H., Baldor L.C., and Russell J.C. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr 132 (2002) 1107-1114
7. Clodfelder B.J., Gullick B.M., Lukaski H.C., Neggers Y., and Vincent J.B. Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. J Biol Inorg Chem 10 (2005) 119-130 [Epub 2004 Dec 30]
8. Shinde Urmila A., Sharma G., Xu Yan J., Dhalla Naranjan S., and Goyal Ramesh K. Anti-diabetic activity and mechanism of action of chromium chloride. Exp Clin Endocrinol Diabetes 112 (2004) 248-252
9. Wilson B.E., and Gondy A. Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res Clin Pract 28 (1995) 179-184
10. Morris B.W., MacNeil S., Stanley K., Gray T.A., and Fraser R. The inter-relationship between insulin and chromium in hyperinsulinaemic euglycaemic clamps in healthy volunteers. J Endocrinol 139 (1993) 339-345
11. Lebovitz H.E. Insulin resistance-a common link between type 2 diabetes and cardiovascular disease. Diabetes Obes Metab 8 (2006) 237-249